The MITRE Corporation / Rhodia Inc. / Hazleton Laboratories America Inc. / Tracor Jitco Inc. / /
Continent
America / /
Facility
National Cancer Institute / DIVISION OF CANCER CAUSE AND PREVENTION NATIONAL CANCER INSTITUTE / G Mason Research Institute / Leesburg Turnpike / Naylor Dana Institute / EG&G Mason Research Institute / /
IndustryTerm
prime contractor / chemical toxicity / Chemical analysis / /
MedicalCondition
tumor / hepatocellular carcinoma / hemangiosarcoma / IOASSAY OF NITROFEN FOR POSSIBLE CARCINOGENICITY CARCINOGENESIS PROGRAM / carcinomas / /
Organization
American Health Foundation / National Cancer Institute / Division of Cancer Cause and Preven / DIVISION OF CANCER CAUSE AND PREVENTION NATIONAL CANCER INSTITUTE / National Institute of Health / BIOASSAY OF NITROFEN FOR POSSIBLE CARCINOGENICITY Carcinogenesis Testing Program Division of Cancer Cause and Prevention National Cancer Institute National Institutes of Health Bethesda / Division of The MITRE Corporation / Center for Regulatory Services / Division of Cancer Cause / Naylor Dana Institute for Disease Prevention / DEPARTMENT OF HEALTH / EG&G Mason Research Institute / /
Person
J. J. Gart / M. R. Kornreich / R. W. Voelker / J. F. Douglas / C. L. Guyton / R. A. Squire / K. C. Chu / L. W. Thomas / W. A. Olson / R. A. Griesemer / E. K. Weisburger / P. Walker / W. W. Belew / K. J. Petrovics / D. G. Goodman / W. M. Weather holtz / /
TR-026 Bioassay of Nitrofen for Possible Carcinogenicity (CAS No[removed])